Akira Suzuki
Profile
Akira Suzuki worked as a Senior Researcher at Fujisawa Pharmaceutical Co., Ltd.
and as a Principal at the Center for Drug Evaluation & Research.
He also served as the Director, Chief Scientific & Corporate Officer at SymBio Pharmaceuticals Ltd.
from 2009 to 2011.
Former positions of Akira Suzuki
Companies | Position | End |
---|---|---|
SYMBIO PHARMACEUTICALS LIMITED | Chief Tech/Sci/R&D Officer | 2011-03-29 |
Center for Drug Evaluation & Research | Corporate Officer/Principal | 1985-12-31 |
Fujisawa Pharmaceutical Co., Ltd.
Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP | Corporate Officer/Principal | - |
Experiences
Positions held
Linked companies
Listed companies | 1 |
---|---|
SYMBIO PHARMACEUTICALS LIMITED | Health Technology |
Private companies | 2 |
---|---|
Fujisawa Pharmaceutical Co., Ltd.
Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP | Health Technology |
Center for Drug Evaluation & Research | Government |
- Stock Market
- Insiders
- Akira Suzuki